362 related articles for article (PubMed ID: 10900217)
1. Evaluation of selective NK(1) receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain.
Gonzalez MI; Field MJ; Hughes J; Singh L
J Pharmacol Exp Ther; 2000 Aug; 294(2):444-50. PubMed ID: 10900217
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain.
Villetti G; Bergamaschi M; Bassani F; Bolzoni PT; Maiorino M; Pietra C; Rondelli I; Chamiot-Clerc P; Simonato M; Barbieri M
J Pharmacol Exp Ther; 2003 Aug; 306(2):804-14. PubMed ID: 12750440
[TBL] [Abstract][Full Text] [Related]
3. Gabapentin and the neurokinin(1) receptor antagonist CI-1021 act synergistically in two rat models of neuropathic pain.
Field MJ; Gonzalez MI; Tallarida RJ; Singh L
J Pharmacol Exp Ther; 2002 Nov; 303(2):730-5. PubMed ID: 12388658
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the central tachykinin NK1 receptor during maintenance of mechanical hypersensitivity induced by diabetes in the rat.
Field MJ; McCleary S; Boden P; Suman-Chauhan N; Hughes J; Singh L
J Pharmacol Exp Ther; 1998 Jun; 285(3):1226-32. PubMed ID: 9618426
[TBL] [Abstract][Full Text] [Related]
5. Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on inflammatory and neuropathic pain in mice.
Marabese I; de Novellis V; Palazzo E; Scafuro MA; Vita D; Rossi F; Maione S
Neuropharmacology; 2007 Feb; 52(2):253-62. PubMed ID: 17113112
[TBL] [Abstract][Full Text] [Related]
6. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A.
Quartaroli M; Carignani C; Dal Forno G; Mugnaini M; Ugolini A; Arban R; Bettelini L; Maraia G; Belardetti F; Reggiani A; Trist DG; Ratti E; Di Fabio R; Corsi M
J Pharmacol Exp Ther; 1999 Jul; 290(1):158-69. PubMed ID: 10381772
[TBL] [Abstract][Full Text] [Related]
7. Behavioural effects of the novel AMPA/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain.
Blackburn-Munro G; Bomholt SF; Erichsen HK
Neuropharmacology; 2004 Sep; 47(3):351-62. PubMed ID: 15275824
[TBL] [Abstract][Full Text] [Related]
8. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
9. Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents.
Field MJ; Oles RJ; Lewis AS; McCleary S; Hughes J; Singh L
Br J Pharmacol; 1997 Aug; 121(8):1513-22. PubMed ID: 9283683
[TBL] [Abstract][Full Text] [Related]
10. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain.
Walker KM; Urban L; Medhurst SJ; Patel S; Panesar M; Fox AJ; McIntyre P
J Pharmacol Exp Ther; 2003 Jan; 304(1):56-62. PubMed ID: 12490575
[TBL] [Abstract][Full Text] [Related]
11. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
Zhao M; Wang JY; Jia H; Tang JS
Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416
[TBL] [Abstract][Full Text] [Related]
12. Comparison of antinociceptive actions of standard analgesics in attenuating capsaicin and nerve-injury-induced mechanical hypersensitivity.
Joshi SK; Hernandez G; Mikusa JP; Zhu CZ; Zhong C; Salyers A; Wismer CT; Chandran P; Decker MW; Honore P
Neuroscience; 2006 Dec; 143(2):587-96. PubMed ID: 16962719
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice.
Mika J; Wawrzczak-Bargiela A; Osikowicz M; Makuch W; Przewlocka B
Brain Behav Immun; 2009 Jan; 23(1):75-84. PubMed ID: 18684397
[TBL] [Abstract][Full Text] [Related]
14. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
[TBL] [Abstract][Full Text] [Related]
15. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
[TBL] [Abstract][Full Text] [Related]
16. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain.
Holdridge SV; Cahill CM
Eur J Pain; 2007 Aug; 11(6):685-93. PubMed ID: 17175187
[TBL] [Abstract][Full Text] [Related]
17. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat.
Honore P; Donnelly-Roberts D; Namovic MT; Hsieh G; Zhu CZ; Mikusa JP; Hernandez G; Zhong C; Gauvin DM; Chandran P; Harris R; Medrano AP; Carroll W; Marsh K; Sullivan JP; Faltynek CR; Jarvis MF
J Pharmacol Exp Ther; 2006 Dec; 319(3):1376-85. PubMed ID: 16982702
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain.
Schiene K; De Vry J; Tzschentke TM
J Pharmacol Exp Ther; 2011 Nov; 339(2):537-44. PubMed ID: 21816956
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of the chronic constriction injury model of neuropathic pain.
De Vry J; Kuhl E; Franken-Kunkel P; Eckel G
Eur J Pharmacol; 2004 May; 491(2-3):137-48. PubMed ID: 15140630
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive effects and toxicity of morphine-6-O-sulfate sodium salt in rat models of pain.
Holtman JR; Crooks PA; Johnson-Hardy J; Wala EP
Eur J Pharmacol; 2010 Dec; 648(1-3):87-94. PubMed ID: 20828549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
